EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, OCTOBER 8, 2025.
Highlights:
- When taken together, the pain medication tramadol and certain antidepressants may raise seizure risk in older adults, according to a new study.
- Researchers studied people living in nursing homes taking tramadol and some antidepressants that inhibit the CYP2D6 enzyme called CYP2D6 inhibitors.
- These antidepressants, such as fluoxetine, paroxetine and bupropion, block the CYP2D6 enzyme needed to metabolize tramadol.
- People taking tramadol and CYP2D6 inhibitors had up to a 9% higher seizure risk than people taking tramadol and antidepressants that do not inhibit the enzyme.
MINNEAPOLIS – When older adults living in nursing homes are prescribed the pain medicine tramadol alongside certain antidepressants, their risk of seizures may go up, according to a study published October 8, 2025, in Neurology®, the medical journal of the American Academy of Neurology. While this study found a link between using the medications together and an increased risk of seizures, it does not prove one causes the other.
Tramadol is an opioid used to treat moderate to severe pain in adults. Some antidepressants that inhibit the CYP2D6 enzyme, called CYP2D6 inhibitors, can interfere with how the body metabolizes tramadol. When the CYP2D6 enzyme is blocked, tramadol is not metabolized properly and may build up in the body, potentially increasing the risk of side effects like seizures. Common CYP2D6-inhibiting antidepressants include fluoxetine, paroxetine and bupropion.
“We found a modest but measurable increase in the risk of seizures when tramadol was taken with antidepressants that inhibit the CYP2D6 enzyme,” said study author Yu-Jung Jenny Wei, PhD, of The Ohio State University in Columbus. “This risk was consistent whether the antidepressant or tramadol was started first.”
Researchers analyzed 10 years of Medicare data to identify 70,156 nursing home residents age 65 and older who had been prescribed both tramadol and an antidepressant.
They divided participants into two groups based on which drugs they took first. Of participants, 11,162 people took tramadol first and then an antidepressant with it, while 58,994 people took an antidepressant first and then added tramadol.
Seizure rates for people who took tramadol first were 16 seizures per 100 person-years, and for people who took antidepressants first, the rate was 20 seizures per 100 person-years. This means for every 100 people who used both tramadol and an antidepressant followed for one year, about 16 or 20 received a seizure diagnosis.
In both groups, researchers then compared seizure rates between those who took tramadol with CYP2D6-inhibiting antidepressants and those who took tramadol with antidepressants that do not inhibit the enzyme. In those who took tramadol first and added an antidepressant, the rate was 18 seizures per 100 person-years for those taking CYP2D6-inhibiting antidepressants compared to 16 seizures per 100 person-years in people taking other antidepressants. In those who took antidepressants first and added tramadol, the rate was 22 seizures per 100 person-years for those taking CYP2D6-inhibiting antidepressants compared to 20 seizures per 100 person-years in people taking other antidepressants.
To help ensure the differences were not due to other health issues, the researchers adjusted for factors such as pain levels, depression symptoms, physical function and cognitive ability.
After adjustments, for people who took tramadol first, seizure risk was 9% higher when taking it with a CYP2D6-inhibiting antidepressant compared to with an antidepressant that did not inhibit this enzyme. For those who took an antidepressant first and added tramadol, the risk was about 6% higher for people who took a CYP2D6-inhibiting antidepressant compared to people who took an antidepressant that did not inhibit the enzyme.
To test whether this interaction was specific to tramadol, the researchers repeated the analysis using hydrocodone, another opioid pain reliever that is unlikely to cause seizure risk when used with antidepressants. No increased seizure risk was observed with hydrocodone and CYP2D6-inhibiting antidepressants.
“These findings underscore the need for careful prescribing practices, especially for older adults with complex health conditions,” said Wei. “Doctors should be aware of potential seizure risks when prescribing tramadol with antidepressants, particularly CYP2D6 inhibitors. Given how commonly both are prescribed to older adults, these interactions may be more important than previously thought.”
A limitation of the study was that medication data came from prescription records, which did not confirm whether patients took the drugs as directed.
This research was supported by the National Institute on Aging.
Discover more about brain health at BrainandLife.org, from the American Academy of Neurology. This resource also offers a magazine, podcast, and books that connect patients, caregivers and anyone interested in brain health with the most trusted information, straight from the world’s leading experts in brain health. Follow Brain & Life® on Facebook, X, and Instagram.
The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.
Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, Instagram, LinkedIn, and YouTube.
Journal
Neurology